Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Equipment
Datasets
Search by expertise, name or affiliation
Prot# NU UIC06CC12: An Open Label Phase II Study of Aprepitant for Multi-Day Moderately-High to Highly Emetogenic Chemotherapy Regimens
Agulnik, Mark
(PD/PI)
Medicine, Hematology Oncology Division
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
9/1/07
→
8/31/08
Funding
University of Illinois at Chicago
(NU UIC06CC12)
Merck & Co., Inc.
(NU UIC06CC12)
View all
View less